Ophtalmic drug market
Global Ophthalmic Drugs Market size was valued at $27 billion in 2017 and is expected to reach $38 billion in 2023, corresponding to a CAGR of 6% from 2017 to 2023. It is noted that the increasing prevalence of eye diseases is the key factor driving the ophthalmic drugs market.
According to the 2017 statistics suggested by the World Health Organization (WHO), around 253 million people are living with vision impairment, out of which 36 million are blind and nearly 217 million have moderate to severe vision impairment. It is also reported that chronic eye diseases are the main cause of vision loss, globally.